PND28 Cost-Effectiveness Analysis of Interferons and Glatiramer Acetate as First Line Treatments in Remitting – Relapsing Multiple Sclerosis Spanish Patients
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.494
https://www.valueinhealthjournal.com/article/S1098-3015(11)02056-0/fulltext
Title :
PND28 Cost-Effectiveness Analysis of Interferons and Glatiramer Acetate as First Line Treatments in Remitting – Relapsing Multiple Sclerosis Spanish Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02056-0&doi=10.1016/j.jval.2011.08.494
First page :
A322
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
466